Investors Overview

Webcast ImageWebcast
Bacterin International Holdings Inc at the Singular Research 9th Annual Best of the Uncovereds Conference (Replay)
09/22/14 at 9:00 a.m. PT
Bacterin International Holdings Inc at the Singular Research 9th Annual Best of the Uncovereds Conference
Monday, September 22, 2014 9:00 a.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Bacterin International Holdings, Inc., Belgrade, MT (NYSE: BONE), a developer of bioactive coatings for medical applications and revolutionary bone graft material, processes and markets innovative, biologic allografts for transplantation. The Company’s biologic scaffolds, OsteoSponge®, OsteoSponge® SC and OsteoWrap®, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets BacFast® and OsteoLock®, which are used in ...
More

Stock Quote
BONE (Common Stock)
ExchangeNYSE (US Dollar)
Price$3.96
Change (%) Stock is Up 0.56 (16.47%)
Volume79,651
Data as of 10/16/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock Chart
Stock chart for: 03NA000000BONE
Recent News
DateTitle 
10/16/14CORRECTING AND REPLACING -- Bacterin Announces Preliminary Third Quarter 2014 Revenue
Third Quarter Total Revenue Expected to be in the Range of $8.4 Million to $8.5 Million, an Increase of Approximately 6 - 7% Over the Same Period Last Year BELGRADE, Mont., Oct. 16, 2014 (GLOBE NEWSWIRE) -- In a release issued on Tuesday, October 14th 2014 by Bacterin International Holdings, Inc. (NYSE MKT:BONE), there was an error in the third paragraph. Please note that the final sentence of the third paragraph should read, "We are now starting to realize the benefits of these investments and... 
Printer Friendly Version
10/16/14Bacterin International Announces Sales Team Expansion
Bacterin Attracts Industry Top Sales Management Talent BELGRADE, Mont., Oct. 16, 2014 (GLOBE NEWSWIRE) -- Bacterin announced today three senior executive additions to its hybrid sales channel. Jeff Whitaker has joined us as Regional Vice President in the Southeast, he brings a track record of success at Stryker Biotech, Mitek Surgical Products (DePuy), and Acufex Microsurgical, Inc. Doug Helling has joined us as Regional Vice President in the South (Texas, Oklahoma), he brings a track r... 
Printer Friendly Version
10/14/14Bacterin Announces Preliminary Third Quarter 2014 Revenue
Third Quarter Total Revenue Expected to be in the Range of $8.4 Million to $8.5 Million, an Increase of Approximately 6 - 7% Over the Same Period Last Year BELGRADE, Mont., Oct. 14, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced preliminary, unaudited revenue for the third quarter of 2014. The Company is expecting total revenue for the thir... 
Printer Friendly Version
10/02/14Bacterin CEO Dan Goldberger to be Guest on Fox Business Network's Opening Bell With Maria Bartiromo
BELGRADE, Mont., Oct. 2, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE:BONE) today announced its CEO Dan Goldberger will be a guest on FOX Business Network's Opening Bell with Maria Bartiromo at approximately 10:40 AM/ET on Friday, October 3, 2014. Bacterin is a medical device company and accredited tissue bank that designs, processes, manufactures, and markets advanced medical products. During the show, Goldberger is expected to talk about the company's growth opportu... 
Printer Friendly Version
More

Upcoming Events
There are currently no events scheduled.
More

Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Bacterin International Holdings Inc posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.